1 September 2013 in Journal of Biological Chemistry
AFAmanda Petrina Scotá Ferreira
Amanda Petrina Scotá Ferreira
+10
The phosphate-dependent transition between enzymatically inert dimers into catalytically capable tetramers has long been the accepted mechanism for the glutaminase activation. Here, we demonstrate that activated glutaminase C (GAC) self-assembles into a helical, fiber-like double-stranded oligomer and propose a molecular model consisting of seven tetramer copies per turn per strand interacting via the N-terminal domains. The loop (321)LRFNKL(326) is projected as the major regulating element for self-assembly and enzyme activation. Furthermore, the previously identified in vivo lysine acetylation (Lys(311) in humans, Lys(316) in mouse) is here proposed as an important down-regulator of superoligomer assembly and protein activation. Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide, a known glutaminase inhibitor, completely disrupted the higher order oligomer, explaining its allosteric mechanism of inhibition via tetramer stabilization. A direct correlation between the tendency to self-assemble and the activity levels of the three mammalian glutaminase isozymes was established, with GAC being the most active enzyme while forming the longest structures. Lastly, the ectopic expression of a fiber-prone superactive GAC mutant in MDA-MB 231 cancer cells provided considerable proliferative advantages to transformed cells. These findings yield unique implications for the development of GAC-oriented therapeutics targeting tumor metabolism.
8 July 2011 in Journal of Materials Chemistry
LOLuciane França de Oliveira
Luciane França de Oliveira
Silver nanoparticles (AgNPs) are attracting attention due to their bactericidal activity and consequent possible biomedical applications. The key to their broad-acting and potent biocidal property seems to be based on the size-related mechanism by which AgNPs act on different bacteria strains. Here, we report the synthesis and successful size-selective fractionation of AgNPs obtained through chemical reduction of silver nitrate in ethylene glycol using polyvinylpyrrolidone as a protective agent. A combination of characterization techniques (UV-vis spectroscopy, transmission electron microscopy and small-angle X-ray scattering) is employed to differentiate the two size-fractionated samples. From the analyses, it is evidenced that AgNPs are mainly spherical and have their radius centered at ∼8.5 and ∼11.0 nm. The nanoparticles bactericidal efficacy is investigated using the disk diffusion test against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis and Micrococcus lysodeikticus. Although both fractionated samples present bactericidal activity against all four tested bacteria (one Gram negative and three Gram positives), those presenting smaller size own enhanced antibacterial properties.
7 November 2017 in BMC Cancer
Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15–20% of breast malignancies are TNBC. Patients with TNBC often have an unfavorable prognosis. In addition, TNBC represents an important clinical challenge since it does not respond to hormone therapy. In this work, we integrated high-throughput mRNA sequencing (RNA-Seq) data from normal and tumor tissues (obtained from The Cancer Genome Atlas, TCGA) and cell lines obtained through in-house sequencing or available from the Gene Expression Omnibus (GEO) to generate a unified list of differentially expressed (DE) genes. Methylome and proteomic data were integrated to our analysis to give further support to our findings. Genes that were overexpressed in TNBC were then curated to retain new potentially druggable targets based on in silico analysis. Knocking-down was used to assess gene importance for TNBC cell proliferation. Our pipeline analysis generated a list of 243 potential new targets for treating TNBC. We finally demonstrated that knock-down of Guanylate-Binding Protein 1 (GBP1 ), one of the candidate genes, selectively affected the growth of TNBC cell lines. Moreover, we showed that GBP1 expression was controlled by epidermal growth factor receptor (EGFR) in breast cancer cell lines. We propose that GBP1 is a new potential druggable therapeutic target for treating TNBC with enhanced EGFR expression.
30 July 2012 in Journal of Materials Chemistry
LOLuciane França de Oliveira
Luciane França de Oliveira
The ever increasing antibiotic resistance levels in pathogenic and non-pathogenic bacteria have boosted the search for effective controlling methods of bacterial infections. In this context, we prepared colloidal silica–lysozyme composites to evaluate the interaction between these structures and bacteria. Lysozyme was chosen since it is a protein that holds bactericidal properties and that, in the reaction process, acts as a catalyst which favors silica hydrolysis and condensation. The high entrapment yield of lysozyme in the silica cage (approximately 95%) does not change the secondary structure of the protein resulting in a material with superior bactericidal properties. The antimicrobial differences when silica–lysozyme composites are tested against Escherichia coli and Staphylococcus aureus are used to propose an interaction mechanism between colloids and bacteria. Bactericidal properties of the composites are attributed to the ultra-structural organization of the composite which, due to the positive surface charge, is attracted by the negative bacterial cell wall while lysozyme is delivered.